By Karen Roman SkylineDx said it can predict metastases and outperform existing staging systems for the country’s second most common type of skin cancer, Cutaneous Squamous Cell Carcinoma (CSCC). The ...
Beyond traditional monitoring of kidney transplant recipients, donor derived-cell free DNA may permit early identification of graft damage.
SkylineDx, an innovative company specializing in molecular diagnostics for dermatology, today announced the latest research on the company's precision molecular diagnostics advances, including a new ...
Researchers from Wageningen University & Research and Van Andel Institute used a variant of CRISPR, a gene-editing tool, to ...
Scientists have unveiled a CRISPR-based tool, ThermoCas9, capable of pinpointing and removing tumor DNA by detecting cancer-specific chemical markers, potentially sparing healthy cells. In parallel, ...
At AACR 2026, prominent cancer researchers discussed the latest advances in mitigating tumor evasion, targeting cancer ...
A novel strategy that combines computational and experimental approaches has allowed researchers at Baylor College of ...
A new study from Karolinska Institutet shows that gene analysis of breast cancer tumors can identify patients who do not ...
Researchers at Karolinska Institutet have developed CDKPredX, a gene expression-based model that identifies breast cancer tumors unlikely to respond to pre-surgery chemotherapy but more responsive to ...
Researchers identified an ecDNA enhancer that drives Myc expression in aggressive brain tumors. Targeting the enhancer resulted in resistance during preclinical studies, prompting the team to propose ...
BioVenic expands its integrated Animal Omics Solutions to support high-resolution, multi-layer animal research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results